Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Size and Share, Epidemiology and Competitive Landscape 2032 | Companies – Novartis Pharmaceuticals, UCB Biopharma, Galapagos NV

May 15 15:48 2023
Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Size and Share, Epidemiology and Competitive Landscape 2032 | Companies - Novartis Pharmaceuticals, UCB Biopharma, Galapagos NV
Non-Radiographic Axial Spondyloarthritis Market
DelveInsight’s “Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) – Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA), historical and forecasted epidemiology as well as the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight launched a new report on “Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Insights, Epidemiology, and Market Forecast-2032.”

Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) is a different kind of inflammatory arthritis. It falls under an umbrella category of diseases called spondyloarthritis, which includes different types of arthritis with one distinguishing feature. There is almost always inflammation in the spine.

Back pain is “the hallmark of Non-Radiographic Axial Spondyloarthritis, which sets it apart from any other type of inflammatory arthritis. “Non-radiographic” means the disease causes symptoms, but there is no visible damage on X-rays, the way there is with a related type of inflammatory arthritis called ankylosing spondylitis.

DelveInsight’s “Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Report 2032“ delivers an in-depth understanding of the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA), historical and forecasted epidemiology as well as the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Request for a detailed sample copy of the report: https://www.delveinsight.com/sample-request/non-radiographic-axial-spondyloarthritis-nr-axspa-market

Non-Radiographic Axial Spondyloarthritis Symptoms:

  • Pain and stiffness in the back or buttocks.
  • Pain that worsens after rest (for example, after waking up) and is relieved by exercise.
  • Pain in tendons (which connect muscles to bones) and ligaments (which connect bones), often felt as pain at the front of the chest, back of the heel or underneath the foot.

“The prevalence of human leukocyte antigen B27 (HLA-B27) was similar for nr-axSpA and AS which is 86.4% for nr-axSpA vs. 89.1% for AS, 74.7% for nr-axSpA vs. 82.2% for AS, and 74.8% for nr-axSpA vs. 81.5% AS.”

Non-Radiographic Axial Spondyloarthritis Key pharma players involved:

  • Novartis Pharmaceuticals
  • UCB Biopharma
  • Galapagos NV

Click here and request free sample pages for our Non-Radiographic Axial Spondyloarthritis Market Outlook 2032.

Table of contents:

1 Key Insight

2 Executive Summary of Non-Radiographic Axial Spondyloarthritis (nr-AxSpA)

3 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Overview at a Glance

4 Disease Background and Overview: Non-Radiographic Axial Spondyloarthritis (nr-AxSpA)

5 Case Reports

6 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Epidemiology and Patient Population

7 United States Epidemiology

8 EU5 Epidemiology

9 Japan Epidemiology

10 Current Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Treatment and Medical Practices

11 Unmet needs

12 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Marketed Drugs

13 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Emerging Drugs

14 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) 7MM Market Analysis

15 United States

16 EU-5 countries: Market Outlook

17 Japan Market Outlook

18 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Drivers

19 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Barriers

20 SWOT Analysis

21 Reimbursement and market access

22 Appendix

23 DelveInsight Capabilities

24 Disclaimer

25 About DelveInsight

View our detailed report: https://www.delveinsight.com/report-store/non-radiographic-axial-spondyloarthritis-nr-axspa-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/